Optical coherence tomography firm Imalux has closed its series A financing and raised a total of $3.5 million, the Cleveland-based company said. The funds will be used to prepare and submit its imaging platform for clearance to market by the U.S. Food and Drug Administration, additional clinical studies, and to lay the groundwork for manufacturing and marketing of the device, Imalux said.
By AuntMinnie.com staff writersSeptember 24, 2003
Copyright © 2003 AuntMinnie.com
